Skip to main content
Equibles

B. Kristine Johnson

Board Member

AtriCure, Inc. (ATRC)

Board Member

ClearPoint Neuro, Inc. (CLPT)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About B. Kristine Johnson

B. Kristine Johnson is recorded as Board Member at AtriCure, Inc. (ATRC) and Board Member at ClearPoint Neuro, Inc. (CLPT). ClearPoint Neuro, Inc. reported in an 8-K filed May 23, 2025 that B. Kristine Johnson was appointed director, effective May 21, 2025. AtriCure, Inc. reported in an 8-K filed May 20, 2025 that B. Kristine Johnson was appointed Director, effective May 19, 2025. ClearPoint Neuro, Inc. reported in an 8-K filed May 16, 2024 that B. Kristine Johnson was appointed director. Equibles holds 4 filed executive changes naming B. Kristine Johnson; each is listed under recent activity with its source filing.

“The following named persons were elected as directors of the Company to serve until the 2026 annual meeting of stockholders or until their successors have been duly elected and qualified or until their earlier death, resignation, disqualification or removal.”
ClearPoint Neuro, Inc. Form 8-K, filed May 23, 2025 · Read the filing
“Each nominee for director was duty elected to serve one-year terms expiring at the 2026 Annual Meeting of Stockholders and until their successors have been duly elected and qualified.”
AtriCure, Inc. Form 8-K, filed May 20, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at AtriCure, Inc.

Other people whose current roles at this company are on record from its filings.

Leadership on record at ClearPoint Neuro, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.